UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056309
Receipt number R000064341
Scientific Title Efficacy Verification of hypersensitivity suppression ingredients
Date of disclosure of the study information 2024/12/09
Last modified on 2025/12/04 10:26:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Lotion Efficacy Verification Test

Acronym

Lotion Efficacy Verification Test

Scientific Title

Efficacy Verification of hypersensitivity suppression ingredients

Scientific Title:Acronym

Efficacy Verification of hypersensitivity suppression ingredients

Region

Japan


Condition

Condition

Sensitive skin

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Verification of the effect of continuous use of the test product on suppression of hypersensitivity and improvement of sensitive skin symptoms

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in skin sensitivity before and after 4 weeks of continuous use of the test product

Key secondary outcomes

Improvement of skin condition by subjective and objective evaluation before and after 4 weeks of continuous use of the test product


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Apply each test product twice a day for 4 weeks.
Right side: Test product A
Left side: Test product A control

Interventions/Control_2

Apply each test product twice a day for 4 weeks.
Right side: Test product A control
Left side: Test product A

Interventions/Control_3

Apply each test product twice a day for 4 weeks.
Right side: Test product B
Left side: Test product B control

Interventions/Control_4

Apply each test product twice a day for 4 weeks.
Right side: Test product B control
Left side: Test product B

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

49 years-old >=

Gender

Female

Key inclusion criteria

(1) Japanese women in their 20s to 40s
(2) Individuals who have given their free and voluntary consent to participate in the study
(3) Those who feel that they have sensitive skin on their faces.
(4) Residents of Tokyo, Saitama, Chiba, and Kanagawa prefectures.

Key exclusion criteria

(1) Currently undergoing dermatological treatment for a skin disorder
(2) Currently participating or scheduled to participate in a study of skin care products for use on the face.
(3) Who have not yet completed at least 2 weeks after the completion of the study of skin care products for use on the face.
(4) Persons with chronic inflammatory diseases
(5) Those with a current allergic skin disease such as atopic dermatitis
(6) Persons with skin diseases or injuries on the skin of the test site that may affect the test
(7) Persons who have allergic symptoms or peculiar constitution to drugs (including citric acid) or cosmetics.
(8) Have a history of serious skin problems (requiring a visit to a dermatologist) due to the use of cosmetics in the past.
(9) Those who have been exposed to significant sunlight (e.g., went to a tanning salon or went swimming) within the past 4 weeks or are scheduled to do so by the end of the examination.
(10) Those who have undergone facial peeling, laser or other cosmetic medical treatment on the face, cosmetic procedures on the face at esthetic clinics, spas, etc., or art make-up within one month.
(11) Any applicant who has undergone cosmetic medical treatment on the examination site
(12) Those who have undergone any special skin care treatment (beauty salon, esthetic salon, etc.) to the test area within the past 4 weeks.
(13) Those who smoke excessively (more than one pack of cigarettes per day, including e-cigarettes) and have an extremely irregular diet
(14) Those who drink excessively (more than 20g/day of alcohol) for more than 6 days a week.
(15) Pregnant, lactating, or planning to become pregnant by the end of the study
(16) Those who cannot read, write, or communicate in Japanese
(17) Those who work irregular hours on a daily basis, such as night shift work or shift work
(18) Those that did not meet certain criteria at screening
(19) Other subjects deemed unsuitable at the discretion of the principal investigator.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Yujiro
Middle name
Last name Endo

Organization

Lion Corporation

Division name

Beauty Care Research Laboratories

Zip code

132-0035

Address

7-2-1 Hirai, Edogawa-ku, Tokyo, Japan

TEL

080-2268-1602

Email

endo_yu@lion.co.jp


Public contact

Name of contact person

1st name Masayuki
Middle name
Last name Nakagawa

Organization

Lion Corporation

Division name

Beauty Care Research Laboratories

Zip code

132-0035

Address

7-2-1 Hirai, Edogawa-ku, Tokyo, Japan

TEL

070-1078-7985

Homepage URL


Email

n-masa@lion.co.jp


Sponsor or person

Institute

Lion Corporation

Institute

Department

Personal name



Funding Source

Organization

Lion Corporation

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Macromill, Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Lion Corporation Clinical Review Committee

Address

7-2-1 Hirai, Edogawa-ku, Tokyo, Japan,132-0035

Tel

03-6739-3711

Email

mukkaz@lion.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

66

Results

This study evaluated a 1% candidate ingredient in a toner used by women with self-reported sensitive skin. Overall, stinging improvement was not statistically confirmed, but a trend toward benefit appeared in the high-sensitivity subgroup. No changes were found in skin physiological parameters or inflammatory cytokines, suggesting possible effects via neuro-related pathways such as TRPV1 or delayed reflection in the stratum corneum.

Results date posted

2025 Year 12 Month 03 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow

Consent Acquisition
Continuous Use of Washout Toner (2 weeks)
Initial Assessment of Skin Condition
Continuous Use of Test Agent (4 weeks)
Assessment of Skin Condition After Continuous Use

Adverse events

The trial was immediately discontinued after confirming five cases of mild skin irritation or peeling. All cases were non-serious and resolved by washing with water or reverting to the skincare products used prior to the trial. The association with the intervention was judged as possible in all cases.

Outcome measures

Skin hypersensitivity
Subjective sensation
Peripheral nerve hypersensitivity
Skin physiological parameters

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 11 Month 25 Day

Date of IRB

2024 Year 11 Month 25 Day

Anticipated trial start date

2024 Year 12 Month 09 Day

Last follow-up date

2025 Year 04 Month 16 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 11 Month 29 Day

Last modified on

2025 Year 12 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064341